BioHarvest Sciences Inc. (BHSC.CN)
CAD 8.9
(1.71%)
CAD 8.9
(1.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.52 Million | -9.24 Million | -6.79 Million | -3.87 Million | -2.38 Million | -2.75 Million |
| Net Income | -12.56 Million | -11.23 Million | -9.82 Million | -6.58 Million | -5.31 Million | -5.13 Million |
| Depreciation & Amortization | 840 Thousand | 712 Thousand | 389 Thousand | 288 Thousand | 324 Thousand | 70 Thousand |
| Deferred income taxes | - | - | 638 Thousand | -87 Thousand | -724 Thousand | - |
| Stock-based compensation | 563 Thousand | 1.35 Million | 3.36 Million | 1.38 Million | 456 Thousand | 269 Thousand |
| Change in working capital | 755 Thousand | -308 Thousand | -96 Thousand | -232 Thousand | 674 Thousand | 136 Thousand |
| Other non-cash items | 866 Thousand | 239 Thousand | -1.26 Million | 1.35 Million | 2.19 Million | 3.43 Million |
| Investing Cash Flow | -1.47 Million | -1.25 Million | -1.64 Million | -173 Thousand | -34 Thousand | -53 Thousand |
| Investments in PPE | -1.47 Million | -1.25 Million | -1.64 Million | -173 Thousand | -34 Thousand | -53 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 13.55 Million | 8.13 Million | 10.77 Million | 4.92 Million | 2.12 Million | 2.22 Million |
| Debt repayment | -13.15 Million | -359 Thousand | -332 Thousand | -312 Thousand | -351 Thousand | -54 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 7.46 Million | 4.46 Million | 742 Thousand | - |
| Other Financing Activities | 403 Thousand | 8.49 Million | 3.63 Million | 769 Thousand | 1.73 Million | 4.06 Million |
| Accounts receivables | -262 Thousand | -159 Thousand | -168 Thousand | -180 Thousand | 6000.00 | 34 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -1.08 Million | -450 Thousand | -828 Thousand | -49 Thousand | 80 Thousand | 40 Thousand |
| Other working capital | 240 Thousand | 301 Thousand | 900 Thousand | -3000.00 | 588 Thousand | 62 Thousand |
| Cash at beginning of period | 1.73 Million | 4.11 Million | 1.78 Million | 911 Thousand | 1.19 Million | 7000.00 |
| Cash at end of period | 5.35 Million | 1.73 Million | 4.11 Million | 1.78 Million | 911 Thousand | 1.19 Million |
| Capital Expenditure | -1.47 Million | -1.25 Million | -1.64 Million | -173 Thousand | -34 Thousand | -53 Thousand |
| Effect of forex changes on cash | 59 Thousand | -22 Thousand | -4000.00 | -6000.00 | 7000.00 | -7000.00 |
| Net cash flow / Change in cash | 3.61 Million | -2.38 Million | 2.33 Million | 872 Thousand | -288 Thousand | 1.19 Million |
| Free Cash Flow | -9.99 Million | -10.49 Million | -8.43 Million | -4.04 Million | -2.41 Million | -2.81 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -687 Thousand | -6.58 Million | -7.23 Million | -12.56 Million | -1.72 Million | -2.85 Million |
| Depreciation & Amortization | 357 Thousand | 202 Thousand | 216 Thousand | 840 Thousand | 217 Thousand | 209 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 194 Thousand | 133 Thousand | 132 Thousand | 563 Thousand | 118 Thousand | 189 Thousand |
| Change in working capital | 344 Thousand | -496 Thousand | -299 Thousand | 755 Thousand | 738 Thousand | -288 Thousand |
| Other non-cash items | 12 Thousand | 162 Thousand | 572 Thousand | 866 Thousand | 146 Thousand | 73 Thousand |
| Investing Cash Flow | -1.93 Million | -222 Thousand | -291 Thousand | -1.47 Million | -440 Thousand | -367 Thousand |
| Investments in PPE | -1.7 Million | -222 Thousand | -291 Thousand | -1.47 Million | -440 Thousand | -367 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -225 Thousand | - | - | - | - | - |
| Financing Cash Flow | 4.6 Million | -116 Thousand | 7 Million | 13.55 Million | 1.18 Million | 4.74 Million |
| Debt repayment | -119 Thousand | -129 Thousand | -7 Million | -13.15 Million | -1.18 Million | -4.34 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 4.72 Million | 13 Thousand | 7.09 Million | 403 Thousand | 1.27 Million | 4.84 Million |
| Accounts receivables | -150 Thousand | 53 Thousand | -174 Thousand | -262 Thousand | -46 Thousand | -43 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 108 Thousand | -210 Thousand | -391 Thousand | -1.08 Million | -82 Thousand | -135 Thousand |
| Other working capital | 75 Thousand | -266 Thousand | 33 Thousand | 240 Thousand | 43 Thousand | 12 Thousand |
| Cash at beginning of period | 3.43 Million | 5.35 Million | 1.55 Million | 1.73 Million | 1.81 Million | 300 Thousand |
| Cash at end of period | 5.16 Million | 3.43 Million | 5.35 Million | 5.35 Million | 1.55 Million | 1.81 Million |
| Capital Expenditure | -1.7 Million | -222 Thousand | -291 Thousand | -1.47 Million | -440 Thousand | -367 Thousand |
| Effect of forex changes on cash | 17 Thousand | -3000.00 | 72 Thousand | 59 Thousand | -1000.00 | 10 Thousand |
| Net cash flow / Change in cash | 1.73 Million | -1.91 Million | 3.79 Million | 3.61 Million | -253 Thousand | 1.51 Million |
| Free Cash Flow | -2.66 Million | -1.8 Million | -3.28 Million | -9.99 Million | -1.43 Million | -3.24 Million |
SCGP-R
DIT
FLGT
REG
9142
HPTO